This study is in progress, not accepting new patients
Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients
a study on Prostate Cancer
Summary
- Eligibility
- for males ages 18 years and up (full criteria)
- Location
- at San Diego, California
- Dates
- study startedestimated completion
- Principal Investigator
- Jessica Wang-Rodriguez, MDGregory A Daniels, MD, PhD
Description
Summary
Official Title
Details
Keywords
Eligibility
Location
Lead Scientists at UCSD
- Jessica Wang-Rodriguez, MD
Professor Of Clinical, Pathology. Authored (or co-authored) 82 research publications - Gregory A Daniels, MD, PhD
Dr. Daniels coordinates our clinical program in melanoma. His own research involves understanding the link between autoimmunity and tumor immunity in developing more effective and less toxic vaccines and immune stimulatory approaches for patients with melanoma.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- OncBioMune Pharmaceuticals
- ID
- NCT02058680
- Phase
- Phase 1
- Study Type
- Interventional
- Last Updated